Monopar Therapeutics (MNPR)

Typically moves ±6.14% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-10 ESTIMATED

Across 21 earnings reports since May 13, 2021, Monopar Therapeutics (MNPR) has a clear post-earnings pattern. It moves ±6.14% on average after reporting and finishes higher 42.9% of the time. Its largest post-earnings gain was +14.55% (Aug 12, 2025) and its largest decline was -24.83% (Nov 10, 2022). The next earnings report is predicted for 2026-08-10 (estimated).

Earnings reactions

How MNPR moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±6.14%

Positive %

42.9%

Negative %

57.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
May 14, 2026	☽ POST	-2.96%	open_in_new
Mar 27, 2026	☽ POST	-1.5%	open_in_new
Nov 13, 2025	☀ PRE	+5.36%	open_in_new
Aug 12, 2025	☀ PRE	+14.55%	open_in_new
May 13, 2025	☀ PRE	-3.65%	open_in_new
Mar 31, 2025	☀ PRE	-9.72%	open_in_new
Nov 08, 2024	☀ PRE	+7.31%	open_in_new
Aug 09, 2024	☀ PRE	-19.64%	open_in_new
May 09, 2024	☀ PRE	-5.2%	open_in_new
Mar 28, 2024	☀ PRE	-7.6%	open_in_new
Nov 09, 2023	☀ PRE	-3.03%	open_in_new
Aug 10, 2023	☀ PRE	+3.17%	open_in_new
May 11, 2023	☀ PRE	-6.6%	open_in_new
Mar 23, 2023	☀ PRE	+0.62%	open_in_new
Nov 10, 2022	☀ PRE	-24.83%	open_in_new
Aug 11, 2022	☀ PRE	+0.27%	open_in_new
May 12, 2022	☽ POST	+9.19%	open_in_new
Mar 24, 2022	☀ PRE	-1.13%	open_in_new
Nov 12, 2021	☀ PRE	-0.2%	open_in_new
Aug 12, 2021	☀ PRE	+1.23%	open_in_new
May 13, 2021	☽ POST	+1.19%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±6.14%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 14 →

Funds holding

$109482338

Total value held

Buying

12 added · 2 reduced

Janus Henderson Group Plc

$72062327 NEW BUY

Blackrock, Inc.

$17344705 +24.21%

State Street Corp

$4840970 +5.20%

Bank Of New York Mellon Corp

$4307490 +21.22%

Bank Of America Corp /De/

$3270908 +838.22%

SEC Filing Types

description SCHEDULE 13G/A

10 chevron_right

description 10-K

9 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
8-K	20260722	open_in_new SEC.gov
S-8 POS	20260722	open_in_new SEC.gov
S-8 POS	20260722	open_in_new SEC.gov
S-8 POS	20260722	open_in_new SEC.gov
S-8 POS	20260722	open_in_new SEC.gov
S-8	20260722	open_in_new SEC.gov
144/A	20260710	open_in_new SEC.gov
144	20260707	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov
4	20260702	open_in_new SEC.gov

Frequently asked about MNPR earnings

When does Monopar Therapeutics report earnings next? expand_more

Monopar Therapeutics (MNPR)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MNPR stock move after earnings? expand_more

Over 21 reports, MNPR has moved an average of ±6.14% the session after earnings, closing higher 42.9% of the time.

What was MNPR's biggest post-earnings move? expand_more

MNPR's largest post-earnings gain on record was +14.55% on Aug 12, 2025, and its largest decline was -24.83% on Nov 10, 2022.

Where can I find Monopar Therapeutics's SEC filings? expand_more

All of Monopar Therapeutics's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.